You searched for "bleeding"
Overcoming sight impairment for the Race Across the World!
RNIB’s Tricia travels the world and takes her message that "sight loss doesn’t stop you doing anything" to BBC One.Ophthalmology in the Middle East: Reflections from two electives in Jordan and the UAE
3 October 2024
| Sarah Suleyman Omran, Andre Ismail
|
EYE - General
In the summer of 2021, I was fortunate enough to embark on two electives in ophthalmology at the Shami Eye Centre in Amman, Jordan, and Moorfields Eye Hospital in Dubai, United Arab Emirates (UAE). These eye hospitals serve distinct populations,...
How the development of Glaucoma Guidelines, Glaucoma Toolkit and GLASS training and the Glaucoma nurse training can effect change in Nigeria
4 February 2025
| Winnie Nolan, Karinya Lewis, Farouk Garba, Fatima Kyari, Elizabeth Ojeyinka, Oteri Okolo, Chimezie Obi-Mgbam, Marcia Zondervan
|
EYE - Glaucoma
In July 2024, a combined training, led by Fatima Kyari, was run in Abuja, Nigeria to facilitate a multifaceted upskilling in glaucoma management. The first week comprised of inviting 36 doctors practising glaucoma from around Nigeria’s 36 states, including the...
‘The Way Forward’ champions clinicians as architects of patient-centred service redesign
The demographic time bomb poses the dilemma of how more healthcare can be delivered to the UK’s ageing population without commensurate growth in resources. The Way Forward Project provides a robust resource for clinical centres to better identify and implement...Progress for a more sustainable practice in ophthalmology
3 October 2024
| Neel Vyas, John Buchan
|
EYE - General
Climate change is widely considered to be the greatest threat to health in the 21st century and is accompanied by other environmental considerations such as air and water pollution that impact on human health [1,2]. These problems are, in no...
Emerging therapies for geographic atrophy: complement inhibitors show potential to slow progression and preserve RPE and photoreceptor integrity
5 June 2023
| Rod McNeil
Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) characterised by progressive, irreversible loss of the retinal pigment epithelium (RPE) and photoreceptors and is estimated to account for approximately 10% of AMD-related blindness [1-4]. The Age-Related Eye...
Moorfields Education: Biometry study day
1 March 2024
This in-person study day has been designed to meet the training needs of nurses, nursing associates, technicians, and anyone with an interest to improve their knowledge and understanding of biometry and its calculation and reading a biometry report.
Dyslexic reading improved by vergence training
The aim of this study was to evaluate if reading performance could be improved by a period of compensatory vergence training in dyslexic children with otherwise normal binocular vision. The study included 13 children with dyslexia – mean age of...My Top Five: Emerging technologies revolutionising ophthalmology
3 October 2024
| Khaled Saqqaw
|
EYE - Vitreo-Retinal, EYE - Cataract, EYE - Refractive, EYE - Cornea
Advancements in ophthalmology have significantly transformed eyecare practices. This article explores five emerging technologies that are revolutionising the field, from virtual reality (VR) surgical training to novel therapies for corneal conditions. These innovations are reshaping how eyecare professionals diagnose, treat...
Pituitary tumours: why are they so often missed?
1 April 2017
| James F (Barry) Cullen
|
EYE - Neuro-ophthalmology
Part 1: Introduction, historical background and Edinburgh connections (see also Part 2 and Part 3) Is there any ophthalmologist who has not missed a pituitary tumour? Hopefully this article will help those currently in practice to avoid such an embarrassment,...
Ranibizumab versus laser in diabetic macular oedema (LUCIDATE study)
1 October 2014
| Efrosini Papagiannuli
|
EYE - Vitreo-Retinal
The aim of this study was to compare the functional and structural effects of Ranibizumab versus macular laser treatment in patients with diabetic macular oedema. It was a single centre, prospective, randomised, single masked clinical trial spanning a 48 week...
Macular atrophy with aflibercept
1 October 2018
| Saruban Pasu
|
EYE - Vitreo-Retinal
The authors of this paper set out to investigate the prevalence of macular atrophy in treatment-naive patients with neovascular AMD undergoing aflibercept monotherapy (three monthly loading injections followed by subsequent treatment every two months). Case notes over a three year...